The Advisory Council on the Misuse of Drugs has been asked to consider the appropriate scheduling of cannabis-related products
Bibliography: Domestic Policy Issues
Home Office Counting Rules for Recorded Crime (PDF)
Drug Offences – Trafficking in Controlled Drugs – Possession of Drugs
Cannabis and cannabis-based medicinal products
The government has announced a review of the scheduling of cannabis (Home Office)
Alcohol and Other Drug Treatment Services in Australia 2016–17
In 2016–17, 836 publicly-funded alcohol and other drug treatment services provided just over 200,000 treatment episodes to an estimated 127,000 clients (AIHW)
Better to Ask Forgiveness Than Permission: Spain’s Sub-national Approach to Drug Policy
Spain represents an important case study for drug policy reform (GDPO)
Adult drug and alcohol misuse treatment business definitions
Business definitions for adult drug and alcohol misuse treatment providers to input data items onto the national drug treatment monitoring system (Public Health England)
Precursor chemical licensing
Licence and registration application information for companies that deal in precursor chemicals (Home Office)
Fentanyl: preparing for a future threat
Incident planning for potent opioids arriving into the illicit drug market (Public Health England)
Inquiry into drug law reform
The key objective of the inquiry was to investigate the effectiveness of drug control laws and procedures in minimising drug‑related harms, as well as drug law reform in other Australian and overseas jurisdictions (Parliament of Victoria)
Uruguay’s cannabis law: Pioneering a new paradigm (PDF)
this report examines the conditions that led Uruguay’s government to pass its cannabis law in 2013, studies its progress so far, and identifies areas that policymakers should consider addressing in order to maximize the law’s potential benefits (WOLA)
Young people drug and alcohol treatment business definitions
Business definitions for young people drug and alcohol treatment providers to input data onto the national drug treatment monitoring system (NDTMS)
Government response to ACMD Report (PDF)
Commissioning impact on drug treatment services ( Department of Health and Social Care)
People powered recovery (PDF)
Social action and complex needs – Findings from a call for evidence (All-Party Parliamentary Group)
Precursor chemical import and export authorisation wallchart
This chart shows the regulation of precursor chemicals in the UK (Home Office)
Drug Consumption Rooms
Debate by UK Parliament
Legitimate use of controlled drugs: research and healthcare
Interim advice to the Home Office regarding the legitimate use of controlled drugs in research and healthcare (ACMD)
Drug misuse and dependence: UK guidelines on clinical management
How clinicians should treat people with drug misuse and drug dependence problems (DoH)
Harm reduction approaches predicted to reduce rates of new hepatitis C infection for people who inject drugs
Needle and syringe exchange appears to be cost-effective, especially if considering the health gains from preventing HIV transmission too. Although the evidence is from observational studies, and the extent of the benefit might uncertain, the nature of the topic makes it difficult to gather evidence in any other way and compared to the cost of treating the consequences of hepatitis later, seems good value (NIHR)
New Psychoactive Substances: the response by probation and substance misuse services in the community in England
A joint inspection by HM Inspectorate of Probation and the Care Quality Commission – download 59 page PDF
The human and financial costs of drug addiction
This is an expansive subject, with a huge number of facets, and is covered by a huge amount of UK and international data. Transcript of debate (House of Commons, UK)
NIDA launches two adolescent substance use screening tools
These tools can be self-administered or completed by clinicians in less than two minutes. They are being offered through the NIDAMED Web Portal
Substance misuse statistics
These reports include statistics from the Welsh National Database for Substance Misuse and additional substance misuse related information available from routinely published sources in Wales (Welsh Government)
The Evaluation of the Drug Recovery Wing Pilots (PDF)
In 2012, the Department of Health commissioned an evaluation of these pilots, which has been undertaken by researchers at the University of York, the Centre for Drug Use Research in Glasgow and the University of Cambridge
The case for a national prescribed drug helpline (PDF)
All Party Parliamentary Group for Prescribed Drug Dependence
Charter for Change
Ten points from The Drugs, Alcohol & Justice Cross-Party Parliamentary Group
Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017 (PDF)
The Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017 (the Bill) seeks to amend the Drugs, Poisons and Controlled Substances Act 1981 (the Principal Act), to provide for the licencing and operation of a medically supervised injecting centre (MSIC) for a trial period of 18 months (Parliament of Victoria, Australia)
Interim report prepared by White House Commission on Combating Drug Addiction and the Opioid Crisis
Recommendations for action (White House)
Widening the availability of naloxone
Naloxone is a prescription-only medicine and cannot therefore be sold over the counter. It can however be supplied without prescription by drug services. It can be used by anyone to save a life in an emergency (DoH)
The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations
This study produced 20 research recommendations on novel psychoactive substance use, for researchers and research commissioners to use in developing the public health evidence-base (NIHR)
Better care for people with co-occurring mental health and alcohol/drug use conditions (PDF)
A guide for commissioners and service providers (Public Health England)
Australian National Drug Strategy 2017-2026
For the first time, Australia has a long-term framework for reducing and preventing the harms associated with alcohol and other drugs through the agreement of a ten-year National Drug Strategy. This is a national strategic framework built on the principles of partnerships, coordination and collaboration, national direction and jurisdictional implementation, and evidence-informed response (Australian Government)
Canada’s Drug Futures Forum (PDF)
Summary of Proceedings and Final Recommendations (CDFF-FADE)
2017 Drug Strategy (PDF)
This Strategy sets out clear expectations for action from a wide range of partners, including those in education, health, safeguarding, criminal justice, housing and employment (HM Government, UK)
Drug misuse and dependence: UK guidelines on clinical management
Often called the Orange Book, this is guidance for clinicians treating people with drug problems (DoH, UK)
Drug-related intimidation – The Irish situation and international responses: an evidence review (PDF)
This report presents the findings of an evidence review on drug-related intimidation (DRI) requested by the Department of Health on behalf of the Local and Regional Drugs and Alcohol Task Forces (HRB)
2017 Drug Strategy (PDF)
This Strategy sets out clear expectations for action from a wide range of partners, including those in education, health, safeguarding, criminal justice, housing and employment (Home Office)
Chickens coming home to roost: local government public health budgets for 2017/18
The Department for Communities and Local Government has released new data on local authorities’ planned budgets for public health in 2017/18. It does not make good reading (King’s Fund)
A Performance Measurement Framework for Drug and Alcohol Task Forces (PDF)
The development of a Performance Measurement Framework for DATFs follows the review undertaken by the Department of Health in 20121 and adopts a similar logic to the Healthy Ireland strategy. Rather than looking at interventions in terms of inputs and outputs, the overriding concern is with the net effect of public policies at the population level. This is the only way of conceptualising effectiveness in an evidence-based and sustainable manner (Drugs and Alcohol Ireland)
Illicit Drug Data Report
Our Illicit Drug Data Report (IDDR) informs Australia’s understanding of the illicit drug threat (ACIC)
Alcohol and other drug treatment services in Australia 2015–16
In 2015–16, about 796 alcohol and other drug treatment services provided just over 206,600 treatment episodes to an estimated 134,000 clients (AIHW)
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 11
- Next Page »
